Parnell Pharmaceuticals (OTCMKTS:PARNF) Lifted to “Buy” at ValuEngine

ValuEngine upgraded shares of Parnell Pharmaceuticals (OTCMKTS:PARNF) from a hold rating to a buy rating in a report published on Thursday morning, ValuEngine reports.

Shares of Parnell Pharmaceuticals stock opened at $0.20 on Thursday. The business has a fifty day simple moving average of $0.28 and a two-hundred day simple moving average of $0.30. Parnell Pharmaceuticals has a 1 year low of $0.12 and a 1 year high of $0.77.

About Parnell Pharmaceuticals

Parnell Pharmaceuticals Holdings Ltd, a veterinary pharmaceutical company, focuses on developing, manufacturing, and commercializing various animal health solutions. The company operates through four segments: Companion Animal, Production Animal — U.S., Production Animal — Rest of World, and Contract Manufacturing.

Read More: The role of implied volatility with call option volume

To view ValuEngine’s full report, visit ValuEngine’s official website.

Receive News & Ratings for Parnell Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Parnell Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.